Results 141 to 150 of about 5,707 (179)

Targeting virulence: can we make evolution-proof drugs?

Nature Reviews Microbiology, 2014
Richard C Allen, Roman Popat, Stephen P Diggle   +2 more
exaly  

Patient education and nonprescription drugs

Patient Education and Counseling, 1986
openaire   +1 more source

Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance

Nature Reviews Drug Discovery, 2017
Gordon Y C Cheung, Michael Otto
exaly  

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Nonprescription Drug Sales Up 11%

American Pharmacy, 1984
openaire   +1 more source

Developing Consumer-Centered, Nonprescription Drug Labeling

American Journal of Preventive Medicine, 2011
Jennifer P. King, Terry C. Davis, Stacy Cooper Bailey, Kara L. Jacobson, Laurie A. Hedlund, Lorenzo Di Francesco, Ruth M. Parker, Michael S. Wolf   +7 more
openaire   +1 more source

Therapeutic Innovation: Ethical Boundaries in the Initial Clinical Trials of New Drugs and Surgical Procedures

Ca-A Cancer Journal for Clinicians, 1970
exaly  

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

Nature Reviews Drug Discovery, 2003
Donald M Coen
exaly  

Palliation and Life Prolongation With Anticancer Drugs

Ca-A Cancer Journal for Clinicians, 1966
exaly  

Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise

Nature Reviews Clinical Oncology, 2019
Daphné Morel, Daniel Jeffery, Sandrine Aspeslagh   +2 more
exaly